Cargando…
Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor
Testicular germ cell tumor (TGCT) is a rare cancer but the most common tumor among adolescent and young adult males. Patients with advanced TGCT often exhibit a worse prognosis due to the acquisition of therapeutic resistance. Cisplatin-based chemotherapy is a standard treatment for advanced TGCTs i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626550/ https://www.ncbi.nlm.nih.gov/pubmed/36319719 http://dx.doi.org/10.1038/s41598-022-21856-3 |
_version_ | 1784822759083212800 |
---|---|
author | Kitayama, Sachi Ikeda, Kazuhiro Sato, Wataru Takeshita, Hideki Kawakami, Satoru Inoue, Satoshi Horie, Kuniko |
author_facet | Kitayama, Sachi Ikeda, Kazuhiro Sato, Wataru Takeshita, Hideki Kawakami, Satoru Inoue, Satoshi Horie, Kuniko |
author_sort | Kitayama, Sachi |
collection | PubMed |
description | Testicular germ cell tumor (TGCT) is a rare cancer but the most common tumor among adolescent and young adult males. Patients with advanced TGCT often exhibit a worse prognosis due to the acquisition of therapeutic resistance. Cisplatin-based chemotherapy is a standard treatment for advanced TGCTs initially sensitive to cisplatin, as exemplified by embryonal carcinoma. The acquisition of cisplatin resistance, however, could be a fatal obstacle for TGCT management. To identify cisplatin resistance-related genes, we performed transcriptome analysis for cisplatin-resistant TGCT cells compared to parental cells. In two types of cisplatin-resistant TGCT cell models that we established from patient-derived TGCT cells, and from the NEC8 cell line, we found that mRNA levels of the high-mobility-group nucleosome-binding gene HMGN5 and meiosis-related gene TEX11 were remarkably upregulated compared to those in the corresponding parental cells. We showed that either HMGN5 or TEX11 knockdown substantially reduced the viability of cisplatin-resistant TGCT cells in the presence of cisplatin. Notably, TEX11 silencing in cisplatin-resistant TGCT cells increased the level of cleaved PARP1 protein, and the percentage of double-strand break marker γH2AX-positive cells. We further demonstrated the therapeutic efficiency of TEX11-specific siRNA on in vivo xenograft models derived from cisplatin-resistant patient-derived TGCT cells. Taken together, the present study provides a potential insight into a mechanism of cisplatin resistance via TEX11-dependent pathways that inhibit apoptosis and DNA damage. We expect that our findings can be applied to the improvement of cisplatin-based chemotherapy for TGCT, particularly for TEX11-overexpressing tumor. |
format | Online Article Text |
id | pubmed-9626550 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96265502022-11-03 Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor Kitayama, Sachi Ikeda, Kazuhiro Sato, Wataru Takeshita, Hideki Kawakami, Satoru Inoue, Satoshi Horie, Kuniko Sci Rep Article Testicular germ cell tumor (TGCT) is a rare cancer but the most common tumor among adolescent and young adult males. Patients with advanced TGCT often exhibit a worse prognosis due to the acquisition of therapeutic resistance. Cisplatin-based chemotherapy is a standard treatment for advanced TGCTs initially sensitive to cisplatin, as exemplified by embryonal carcinoma. The acquisition of cisplatin resistance, however, could be a fatal obstacle for TGCT management. To identify cisplatin resistance-related genes, we performed transcriptome analysis for cisplatin-resistant TGCT cells compared to parental cells. In two types of cisplatin-resistant TGCT cell models that we established from patient-derived TGCT cells, and from the NEC8 cell line, we found that mRNA levels of the high-mobility-group nucleosome-binding gene HMGN5 and meiosis-related gene TEX11 were remarkably upregulated compared to those in the corresponding parental cells. We showed that either HMGN5 or TEX11 knockdown substantially reduced the viability of cisplatin-resistant TGCT cells in the presence of cisplatin. Notably, TEX11 silencing in cisplatin-resistant TGCT cells increased the level of cleaved PARP1 protein, and the percentage of double-strand break marker γH2AX-positive cells. We further demonstrated the therapeutic efficiency of TEX11-specific siRNA on in vivo xenograft models derived from cisplatin-resistant patient-derived TGCT cells. Taken together, the present study provides a potential insight into a mechanism of cisplatin resistance via TEX11-dependent pathways that inhibit apoptosis and DNA damage. We expect that our findings can be applied to the improvement of cisplatin-based chemotherapy for TGCT, particularly for TEX11-overexpressing tumor. Nature Publishing Group UK 2022-11-01 /pmc/articles/PMC9626550/ /pubmed/36319719 http://dx.doi.org/10.1038/s41598-022-21856-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kitayama, Sachi Ikeda, Kazuhiro Sato, Wataru Takeshita, Hideki Kawakami, Satoru Inoue, Satoshi Horie, Kuniko Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title | Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title_full | Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title_fullStr | Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title_full_unstemmed | Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title_short | Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor |
title_sort | testis-expressed gene 11 inhibits cisplatin-induced dna damage and contributes to chemoresistance in testicular germ cell tumor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626550/ https://www.ncbi.nlm.nih.gov/pubmed/36319719 http://dx.doi.org/10.1038/s41598-022-21856-3 |
work_keys_str_mv | AT kitayamasachi testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT ikedakazuhiro testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT satowataru testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT takeshitahideki testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT kawakamisatoru testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT inouesatoshi testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor AT horiekuniko testisexpressedgene11inhibitscisplatininduceddnadamageandcontributestochemoresistanceintesticulargermcelltumor |